Literature DB >> 10896520

From the Food and Drug Administration.

J E Henney.   

Abstract

Mesh:

Substances:

Year:  2000        PMID: 10896520

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  7 in total

1.  Verteporfin induced SUMOylation of YAP1 in endometrial cancer.

Authors:  Bo Wang; Wenyu Shao; Yue Shi; Jiongbo Liao; Xiaojun Chen; Chao Wang
Journal:  Am J Cancer Res       Date:  2020-04-01       Impact factor: 6.166

2.  Efflux pump inhibitor potentiates antimicrobial photodynamic inactivation of Enterococcus faecalis biofilm.

Authors:  Anil Kishen; Megha Upadya; George P Tegos; Michael R Hamblin
Journal:  Photochem Photobiol       Date:  2010-09-22       Impact factor: 3.421

3.  YAP/TAZ-Mediated Upregulation of GAB2 Leads to Increased Sensitivity to Growth Factor-Induced Activation of the PI3K Pathway.

Authors:  Chao Wang; Chao Gu; Kang Jin Jeong; Dong Zhang; Wei Guo; Yiling Lu; Zhenlin Ju; Nattapon Panupinthu; Ji Yeon Yang; Mihai Mike Gagea; Patrick Kwok Shing Ng; Fan Zhang; Gordon B Mills
Journal:  Cancer Res       Date:  2017-02-15       Impact factor: 12.701

4.  Verteporfin inhibits YAP function through up-regulating 14-3-3σ sequestering YAP in the cytoplasm.

Authors:  Chao Wang; Xiaoyong Zhu; Weiwei Feng; Yinhua Yu; Kangjin Jeong; Wei Guo; Yiling Lu; Gordon B Mills
Journal:  Am J Cancer Res       Date:  2015-12-15       Impact factor: 6.166

5.  Verteporfin suppresses cell survival, angiogenesis and vasculogenic mimicry of pancreatic ductal adenocarcinoma via disrupting the YAP-TEAD complex.

Authors:  Honglong Wei; Fuhai Wang; Yong Wang; Tao Li; Peng Xiu; Jingtao Zhong; Xueying Sun; Jie Li
Journal:  Cancer Sci       Date:  2017-03       Impact factor: 6.716

6.  Regulation of Hippo-YAP signaling by insulin-like growth factor-1 receptor in the tumorigenesis of diffuse large B-cell lymphoma.

Authors:  Xiangxiang Zhou; Na Chen; Hongzhi Xu; Xiaoming Zhou; Jianhong Wang; Xiaosheng Fang; Ya Zhang; Ying Li; Juan Yang; Xin Wang
Journal:  J Hematol Oncol       Date:  2020-06-16       Impact factor: 17.388

7.  Inhibition of Yes-Associated Protein-1 (YAP1) Enhances the Response of Invasive Breast Cancer Cells to the Standard Therapy.

Authors:  Maha Guimei; Sana Alrouh; Maha Saber-Ayad; Shirin A Hafezi; Arya Vinod; Surendra Rawat; Yazan Wardeh; Tala Mohamad Bakkour; Ahmed Taher El-Serafi
Journal:  Breast Cancer (Dove Med Press)       Date:  2020-11-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.